Street Calls of the Week
Evercore initiates Lumentum (LITE) at Outperform with a $1,100 target, citing strong demand for Indium Phosphide lasers in AI. Jefferies upgrades Sempra Energy (SRE) to Buy, seeing undervaluation. TD Cowen downgrades Eyepoint (EYPT) to Hold, citing poor trial results. Truist downgrades Covista (CVSA) to Hold, citing valuation concerns. Baird upgrades Sonida Senior Living (SNDA) to Outperform, citing demographic trends.
How this was made
The 30-second read
Why it matters
Each analyst action provides a fresh catalyst that could move the respective stock, though the overall impact is modest.
Market read
Analyst rating changes can prompt short‑term trading activity, but the article is a summary rather than a primary market‑moving event.
What to watch
Potential macro‑economic headwinds and regulatory developments could dampen the expected upside.
Background
The article compiles a weekly set of analyst upgrades and downgrades across five US‑listed companies.
Ticker impact
Evercore initiates Lumentum Holdings at Outperform with a $1,100 price target and FY28 EPS forecast of $35‑$50.
Potential price appreciation toward the $1,100 target.
Analyst upgrade with aggressive earnings projection indicates a bullish catalyst.
Jefferies upgrades Sempra Energy to Buy, citing mispricing after Texas transmission capex delays.
Likely modest upside as investors reprice the perceived discount.
Upgrade reflects a view that current price undervalues the asset despite operational headwinds.
TD Cowen downgrades Eyepoint Pharmaceuticals to Hold and cuts the price target to $4 after a Phase III trial flop.
Potential downside pressure toward the $4 target.
Negative trial results and lowered target suggest weaker near‑term prospects.
Truist downgrades Covista Inc to Hold from Buy, keeping the $140 price target amid AI‑related concerns.
Possible price stagnation or modest decline.
Analyst doubts about AI impact and sector headwinds temper expectations.
Baird upgrades Sonida Senior Living to Outperform with a $43 price target, citing pricing power and recent merger integration.
Potential upside toward the $43 target.
Analyst sees durable pricing power and successful integration as catalysts.
Market effects
Highlights mixed sentiment across AI‑related hardware, utilities, biotech, education services, and senior housing sectors.
US‑focused analyst actions may influence broader market sentiment in the respective sectors.
Limited; primarily affects US‑listed equities.
Counterpoint
Some investors may view the upgrades as premature given underlying operational risks, especially in AI‑exposed names.
Key entities
- Research FirmEvercore
Initiated coverage of Lumentum Holdings.
- Research FirmJefferies
Upgraded Sempra Energy.
- Research FirmTD Cowen
Downgraded Eyepoint Pharmaceuticals.
- Research FirmTruist
Downgraded Covista Inc.
- Research FirmBaird
Upgraded Sonida Senior Living.
